IRIS Accounts Production v25.4.0.155 Other Company accounts True false Pounds 1.4.24 31.3.25 31.3.25 FY FRS 102 Independent examiner Small companies regime for accounts Full Charities SORP true true true true false true false true iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh027910562024-03-31027910562025-03-31027910562024-04-012025-03-31027910562023-03-31027910562023-04-012024-03-31027910562024-03-3102791056ns0:CharitableCompanyLimitedByGuarantee2024-04-012025-03-3102791056ns15:PoundSterling2024-04-012025-03-3102791056ns11:FRS1022024-04-012025-03-3102791056ns11:IndependentExaminationCharity2024-04-012025-03-3102791056ns11:SmallCompaniesRegimeForAccounts2024-04-012025-03-3102791056ns11:FullAccounts2024-04-012025-03-3102791056ns11:CharitiesSORP2024-04-012025-03-3102791056ns16:EnglandWales2024-04-012025-03-3102791056ns11:RegisteredOffice2024-04-012025-03-3102791056ns0:Trustee12024-04-012025-03-3102791056ns0:Trustee22024-04-012025-03-3102791056ns11:CompanySecretary12024-04-012025-03-3102791056ns0:TotalUnrestrictedFunds2024-04-012025-03-3102791056ns0:TotalRestrictedIncomeFunds2024-04-012025-03-3102791056ns0:Activity82024-04-012025-03-3102791056ns0:TotalUnrestrictedFundsns0:Activity82024-04-012025-03-3102791056ns0:Activity8ns0:TotalRestrictedIncomeFunds2024-04-012025-03-3102791056ns0:Activity82023-04-012024-03-3102791056ns0:TotalUnrestrictedFunds2024-03-3102791056ns0:TotalRestrictedIncomeFunds2024-03-3102791056ns0:TotalUnrestrictedFunds2025-03-3102791056ns0:TotalRestrictedIncomeFunds2025-03-3102791056ns0:TotalUnrestrictedFundsns10:WithinOneYear2025-03-3102791056ns10:WithinOneYearns0:TotalRestrictedIncomeFunds2025-03-3102791056ns10:WithinOneYear2025-03-3102791056ns10:WithinOneYear2024-03-3102791056ns10:PlantMachinery2024-04-012025-03-3102791056ns10:FurnitureFittingsToolsEquipment2024-04-012025-03-3102791056ns10:ComputerEquipment2024-04-012025-03-310279105622024-04-012025-03-310279105612024-04-012025-03-310279105612023-04-012024-03-310279105642024-04-012025-03-310279105642023-04-012024-03-310279105652024-04-012025-03-310279105652023-04-012024-03-3102791056ns10:OwnedAssets2024-04-012025-03-3102791056ns10:OwnedAssets2023-04-012024-03-3102791056ns0:TotalUnrestrictedFunds2023-04-012024-03-3102791056ns0:TotalRestrictedIncomeFunds2023-04-012024-03-3102791056ns0:TotalUnrestrictedFundsns0:Activity82023-04-012024-03-3102791056ns0:Activity8ns0:TotalRestrictedIncomeFunds2023-04-012024-03-3102791056ns10:PlantMachinery2024-03-3102791056ns10:FurnitureFittings2024-03-3102791056ns10:ComputerEquipment2024-03-3102791056ns10:FurnitureFittings2024-04-012025-03-3102791056ns10:PlantMachinery2025-03-3102791056ns10:FurnitureFittings2025-03-3102791056ns10:ComputerEquipment2025-03-3102791056ns10:PlantMachinery2024-03-3102791056ns10:FurnitureFittings2024-03-3102791056ns10:ComputerEquipment2024-03-31
REGISTERED COMPANY NUMBER: 02791056 (England and Wales)
REGISTERED CHARITY NUMBER: 1017488














Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

M.K. Multiple Sclerosis Therapy Group
Limited

M.K. Multiple Sclerosis Therapy Group
Limited






Contents of the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2025




Page

Report of the Trustees 1 to 2

Independent Examiner's Report 3

Statement of Financial Activities 4

Balance Sheet 5 to 6

Notes to the Financial Statements 7 to 12

M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Report of the Trustees
FOR THE YEAR ENDED 31 MARCH 2025


Trustee report for year ended 31st March 2025

The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31st March 2025. The trustees have adopted the provisions of the Charities (SORP) FRS102 'Accounting and Reporting by Charities' (effective 1st January 2015).

Principal Activity

The Company was incorporated to provide relief to sufferers of Multiple Sclerosis from a permanent base in Milton Keynes. (MKMSTG) We also treat other conditions such as Fibromyalgia, Parkinson's, Arthritis, Cancer, Cerebral Palsy (CP), Autism, Long Covid and Sports Injury. Funds for the upkeep of the centre are generated by payment for treatment, fund raising, sponsorship, donations, subscription and grants.

Review of activities

The financial year April 2024 to March 2025 has been a busy year for the Therapy Centre. Membership has been growing steadily throughout the year but it has been noticeable that members with other conditions have overtaken those with Multiple Sclerosis particularly those having Hyper-baric Oxygen Therapy.
In May 2024 we celebrated our 31st year anniversary for MKMSTG with a very successful Open Day. Many people came to help us celebrate with a mixture of members, supporters, health professionals and local dignitaries. The Mayors of Milton Keynes and Wolverton attended.
In October we held our Annual General Meeting to present the yearly accounts to members. The Trustees were pleased that most of the Committee were voted back to continue volunteering as Operators and Committee members. Our long standing Secretary Sheila Stockton decided not to stand for re-election this year. However, Sheila will continue helping with new member's paperwork, running the website, being our IT expert and helping the Centre Manager with many other administrative jobs.
Two of our long standing volunteers agreed to join the Board of Trustees, Mrs Chris Warburton and Mrs Claire Boreham Hill. This brings the number of Trustees to four.
In December we held our annual mincepie morning with a Christmas raffle. It was very well attended by volunteers and members. Thank you to all who kindly provided us with some really great prizes.
The state of the building and the subsidence is still being monitored by the Insurers and the Agent Kirkby Diamond on behalf of Landlords, MK Community Foundation.

Operating Income

Operating income for this accounting period (which includes payments and subscriptions) was £38,692 almost the same as last year. Donations/fundraising was £3,695 slightly up on last year. Our thanks to Ontario Ladies Choir, The Lenborough Singers, Lions Club, Robert Stanley, Oddfellows and our generous members. Total Income was £43,379, Expenditure was £53,744. During this financial year some utilities were particularly high. Fortunately, our Centre Manager Sharn was able to negotiate new contracts which have significantly reduced the size of current, and hopefully future, invoices. At the end of the year we transferred £4000 from the Building fund at the Coventry building Society, to cover bills due at the end of December. The total of the Building fund now stands at £98,165 before interest. The Treasurer hopes to replace this transfer during 2025.

The Trustees would like to thank the Centre Manager, Sharn Nandhra, The Committee and Chair Chris Warburton, Secretary Caroline Musgrove, Volunteer Operators and Therapists for their work, dedication and help in continuing to keep the MK MS Therapy Centre open and operating safely. We continue providing much needed therapies for our members within the local community and wider area. Our thanks also go to our Patron, Dr Fernandes and the Management team, for their continued dedication and support.
The Trustees would also like to thank Sheila Stockton for her support as a Committee member and Secretary.


M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Report of the Trustees
FOR THE YEAR ENDED 31 MARCH 2025

STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee as defined by the Companies Act 2006.

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
02791056 (England and Wales)

Registered Charity number
1017488

Registered office
4 Hollin Lane
Stacey Bushes
Milton Keynes
Buckinghamshire
MK12 6HT

Trustees
Ms R Heredia Managing Director
Ms J Bohn Company Secretary

Company Secretary
Ms J Bohn

Independent Examiner
Declan Connolly FCCA
Connolly Accountants & Business Advisors Ltd
Chartered Certified Accountants
The Stable Yard
25-33 Vicarage Road
Stony Stratford
Milton Keynes
Buckinghamshire
MK11 1BN

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

Approved by order of the board of trustees on 20 October 2025 and signed on its behalf by:





Ms R Heredia - Trustee

Independent Examiner's Report to the Trustees of
M.K. Multiple Sclerosis Therapy Group
Limited

Independent examiner's report to the trustees of M.K. Multiple Sclerosis Therapy Group Limited ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2025.

Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.








Declan Connolly FCCA

Connolly Accountants & Business Advisors Ltd
Chartered Certified Accountants
The Stable Yard
25-33 Vicarage Road
Stony Stratford
Milton Keynes
Buckinghamshire
MK11 1BN

20 October 2025

M.K. Multiple Sclerosis Therapy Group
Limited

Statement of Financial Activities
FOR THE YEAR ENDED 31 MARCH 2025

2025 2024
Unrestricted Restricted Total Total
funds fund funds funds
Notes £    £    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 43,285 - 43,285 77,818

Other trading activities 2 95 - 95 72
Investment income 3 2,895 - 2,895 2,375
Total 46,275 - 46,275 80,265

EXPENDITURE ON
Raising funds 4 28,722 - 28,722 40,391

Charitable activities
Fundraising 24,841 182 25,023 16,499

Other - - - 720
Total 53,563 182 53,745 57,610

NET INCOME/(EXPENDITURE) (7,288 ) (182 ) (7,470 ) 22,655


RECONCILIATION OF FUNDS
Total funds brought forward 112,465 3,083 115,548 92,893

TOTAL FUNDS CARRIED FORWARD 105,177 2,901 108,078 115,548

M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Balance Sheet
31 MARCH 2025

2025 2024
Unrestricted Restricted Total Total
funds fund funds funds
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 9 162 181 343 834

CURRENT ASSETS
Debtors 10 2,303 - 2,303 2,119
Cash at bank and in hand 103,594 2,720 106,314 113,426
105,897 2,720 108,617 115,545

CREDITORS
Amounts falling due within one year 11 (882 ) - (882 ) (831 )

NET CURRENT ASSETS 105,015 2,720 107,735 114,714

TOTAL ASSETS LESS CURRENT
LIABILITIES

105,177

2,901

108,078

115,548

NET ASSETS 105,177 2,901 108,078 115,548
FUNDS 13
Unrestricted funds:
General fund 105,177 112,465
Restricted funds:
General Fund Restricted 2,901 3,083
TOTAL FUNDS 108,078 115,548

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.


The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.


M.K. Multiple Sclerosis Therapy Group
Limited (Registered number: 02791056)

Balance Sheet - continued
31 MARCH 2025

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.


The financial statements were approved by the Board of Trustees and authorised for issue on 20 October 2025 and were signed on its behalf by:





R Heredia - Trustee





J Bohn - Trustee

M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements
FOR THE YEAR ENDED 31 MARCH 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.


Plant and machinery - 25% on cost
Fixtures and fittings - 3 years
Computer equipment - 3 years

Taxation
The charity is exempt from corporation tax on its charitable activities.

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the period of the lease.


M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. OTHER TRADING ACTIVITIES
2025 2024
£    £   
Shop sales income 95 72

3. INVESTMENT INCOME
2025 2024
£    £   
Deposit account interest 2,895 2,375

4. RAISING FUNDS

Raising donations and legacies
2025 2024
£    £   
Rent 5,825 5,205
Rates and water 113 495
Insurance 2,334 2,115
Light and heat 3,808 4,922
Telephone 954 739
Postage and stationery 439 234
HBO costs 12,306 9,152
Fund raising - raffle - 11
Fundraising 86 4,593
Support costs - 9,271
25,865 36,737

5. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

2025 2024
£    £   
Depreciation - owned assets 491 664
Rent 5,825 5,205

6. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024.


Trustees' expenses

There were no trustees' expenses paid for the year ended 31 March 2025 nor for the year ended 31 March 2024.



M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2025

7. STAFF COSTS

The average monthly number of employees during the year was as follows:

2025 2024
Trustees 4 2

No employees received emoluments in excess of £60,000.

8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted Restricted Total
funds fund funds
£    £    £   
INCOME AND ENDOWMENTS FROM
Donations and legacies 75,098 2,720 77,818

Other trading activities 72 - 72
Investment income 2,375 - 2,375
Total 77,545 2,720 80,265

EXPENDITURE ON
Raising funds 40,210 181 40,391

Charitable activities
Fundraising 16,499 - 16,499

Other 720 - 720
Total 57,429 181 57,610

NET INCOME 20,116 2,539 22,655


RECONCILIATION OF FUNDS
Total funds brought forward 92,349 544 92,893

TOTAL FUNDS CARRIED FORWARD 112,465 3,083 115,548


M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2025

9. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2024 and 31 March 2025 48,408 22,947 2,271 73,626
DEPRECIATION
At 1 April 2024 48,046 22,944 1,802 72,792
Charge for year 181 3 307 491
At 31 March 2025 48,227 22,947 2,109 73,283
NET BOOK VALUE
At 31 March 2025 181 - 162 343
At 31 March 2024 362 3 469 834

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Prepayments 2,303 2,119

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Accrued expenses 882 831

12. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

2025 2024
£    £   
Within one year 6,447 5,247

13. MOVEMENT IN FUNDS
Net
movement At
At 1.4.24 in funds 31.3.25
£    £    £   
Unrestricted funds
General fund 112,465 (7,288 ) 105,177

Restricted funds
General Fund Restricted 3,083 (182 ) 2,901

TOTAL FUNDS 115,548 (7,470 ) 108,078

M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2025

13. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 46,275 (53,563 ) (7,288 )

Restricted funds
General Fund Restricted - (182 ) (182 )

TOTAL FUNDS 46,275 (53,745 ) (7,470 )


Comparatives for movement in funds

Net
movement At
At 1.4.23 in funds 31.3.24
£    £    £   
Unrestricted funds
General fund 92,349 20,116 112,465

Restricted funds
General Fund Restricted 544 2,539 3,083

TOTAL FUNDS 92,893 22,655 115,548

Comparative net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 77,545 (57,429 ) 20,116

Restricted funds
General Fund Restricted 2,720 (181 ) 2,539

TOTAL FUNDS 80,265 (57,610 ) 22,655

M.K. Multiple Sclerosis Therapy Group
Limited

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 MARCH 2025

13. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Net
movement At
At 1.4.23 in funds 31.3.25
£    £    £   
Unrestricted funds
General fund 92,349 12,828 105,177

Restricted funds
General Fund Restricted 544 2,357 2,901

TOTAL FUNDS 92,893 15,185 108,078

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 123,820 (110,992 ) 12,828

Restricted funds
General Fund Restricted 2,720 (363 ) 2,357

TOTAL FUNDS 126,540 (111,355 ) 15,185

14. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2025.